XML 31 R16.htm IDEA: XBRL DOCUMENT

Stock-Based Compensation

12 Months Ended

Dec. 31, 2020

Share-based Payment Arrangement [Abstract]

9.	Stock-Based Compensation

We have adopted equity incentive plans for which stock options and restricted stock awards are available to grant to employees, consultants and directors. Except for certain options granted to certain Swedish employees, all employee, consultant and director stock options granted under our stock option plans have an exercise price equal to the market value of the underlying common stock on the grant date. There are no vesting provisions tied to performance conditions for any options, as vesting for all outstanding option grants was based only on continued service as an employee, consultant or director. All of our outstanding stock options and restricted stock awards are classified as equity instruments.

Stock Options / Stock Awards

During the year ended December 31, 2020, our stockholders approved the Neonode Inc. 2020 Stock Incentive Plan (the “2020 Plan”) which replaced our 2015 Stock Incentive Plan (the “2015 Plan”), which in turn replaced our Neonode Inc. 2006 Equity Incentive Plan (the “2006 Plan”). Although no new awards may be made under the 2015 or 2006 Plans, they are still operative for previously granted awards. Under the 2020 Plan, 750,000 shares of common stock have been reserved for awards, including nonqualified stock option grants and restricted stock grants to officers, employees, non-employee directors and consultants. The terms of the awards granted under the 2020 Plan are set by our compensation committee at its discretion.

Accordingly, as of December 31, 2020, we had three equity incentive plans:

	●	The 2006 Equity Incentive Plan (the “2006 Plan”).

	●	The 2015 Equity Incentive Plan (the “2015 Plan”).

	●	The 2020 Equity Incentive Plan (the “2020 Plan”).

In 2020 we established the Neonode Inc. 2020 Long Term Incentive Plan (the “2020 LTIP”) to provide eligible persons with the opportunity to acquire an equity interest, or otherwise increase their equity interest, in the Company as an incentive for them to remain in the service of the Company. Through the 2020 LTIP, eligible employees of Neonode may waive between 50% to 67% of future unearned bonuses that may be awarded to them under the Company’s annual bonus arrangement in exchange for the grant of shares of the Company’s common stock.

On December 29, 2020, we issued 37,288 shares of common stock to key employees pursuant to the 2020 LTIP. The shares were immediately vested but subject to a two-year lock-up period after issuance. In the event the participant’s employment with Neonode is terminated by the participant during the two-year lock-up period, the Company will repurchase the shares at a price equal to 30% of the lower of market value at issuance and termination date. The shares issued on December 29, 2020 represent two-thirds of the total shares available for issuance under the 2020 LTIP and the last one-third is planned to be issued at the end of December 2021. Neonode has reported and paid Swedish social charges of $75,000 for the issued shares but only 30% of the stock-based compensation (totaling $77,000) is included in the consolidated statement of operations for the year ended December 31, 2020, with the remainder to be recognized ratably over the two-year lock-up period.

The following table summarizes information with respect to all options to purchase shares of common stock outstanding under the 2006 Plan, the 2015 Plan and the 2020 Plan at December 31, 2020:

Options Outstanding
Range of Exercise Price	Number Outstanding and exercisable at 12/31/20		Weighted Average Remaining Contractual Life (years)		Weighted Average Exercise Price

$ 0 - $ 15.00		2,500		0.62	$	14.40
$ 15.01 - $ 30.40		7,000		0.78	$	30.40
$ 30.40 - $ 62.10		1,000		0.00	$	62.10
		10,500		1.40	$	29.61

A summary of the combined activity under all of the stock option plans is set forth below:

	Options Outstanding
						Weighted-
						Average
				Weighted-		Remaining
				Average		Contractual		Aggregate
	Number of			Exercise		Life		Intrinsic
	Shares			Price		(in years)		Value
Options outstanding – January 1, 2019		99,800		$	34.55		1.41	$	-
Options granted		-			-				-
Options exercised		-			-				-
Options cancelled or expired		(47,300	)		42.35				-
Options outstanding – December 31, 2019		52,500		$	27.51		1.37		-
Options granted		-			-				-
Options exercised		-			-				-
Options cancelled or expired		(42,000	)		26.99				-
Options outstanding and vested – December 31, 2020		10,500		$	29.61		1.40	$	-

No stock options were granted during the years ended December 31, 2020 and 2019, respectively.

During the years ended December 31, 2020 and 2019, we recorded no stock-based compensation expense related to the vesting of stock options. The estimated fair value of the stock options was calculated using the Black-Scholes option pricing model as of the grant date of the stock option.

Stock options granted under the 2006 and 2015 Plans are exercisable over a maximum term of ten years from the date of grant, vest in various installments over a one to four-year period and have exercise prices reflecting the market value of the shares of common stock on the date of grant.

Stock-Based Compensation

The stock-based compensation expense for the years ended December 31, 2020 and 2019 reflects the estimated fair value of the vested portion of common stock granted to directors and employees (in thousands):

	Years ended December 31,
	2020		2019
(In thousands)
Sales and marketing	$	32	$	-
General and administrative		45		-
Stock-based compensation expense	$	77	$	-

There is no remaining unrecognized compensation expense related to stock options as of December 31, 2020. Unrecognized compensation expense related to the 2020 LTIP as of December 31, 2020 was $177,000, which will be recognized over two years.